Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Accumulated Expenses: 2020-2022

Historic Accumulated Expenses for Terns Pharmaceuticals (TERN) over the last 3 years, with Dec 2022 value amounting to $6.2 million.

  • Terns Pharmaceuticals' Accumulated Expenses rose 70.58% to $8.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $8.1 million, marking a year-over-year increase of 70.58%. This contributed to the annual value of $6.2 million for FY2022, which is 31.27% up from last year.
  • Per Terns Pharmaceuticals' latest filing, its Accumulated Expenses stood at $6.2 million for FY2022, which was up 31.27% from $4.7 million recorded in FY2021.
  • In the past 5 years, Terns Pharmaceuticals' Accumulated Expenses registered a high of $9.0 million during FY2020, and its lowest value of $4.7 million during FY2021.
  • Its 3-year average for Accumulated Expenses is $6.6 million, with a median of $6.2 million in 2022.
  • Per our database at Business Quant, Terns Pharmaceuticals' Accumulated Expenses crashed by 47.88% in 2021 and then soared by 31.27% in 2022.
  • Terns Pharmaceuticals' Accumulated Expenses (Yearly) stood at $9.0 million in 2020, then plummeted by 47.88% to $4.7 million in 2021, then skyrocketed by 31.27% to $6.2 million in 2022.